Tuesday, October 20, 2026
Saga
Iambic Therapeutics IPO
Overview
Description Iambic Therapeutics is completing its Nasdaq IPO while presenting its AI-enabled oncology drug-discovery platform to public investors. Overview Iambic Therapeutics filed for an initial public offering and planned to list on Nasdaq under the ticker IAM. The AI-driven cancer drugmaker raised $150 million in a U.S. IPO…
Keeping an eye on this saga?
Tilt can alert you when its scenarios shift, or send you a recommendation when one crosses a threshold.
Stories in this saga
1 story, 1 source
Oct 15, 2026
